Overview
Aleksandra Bozaric-Vuksanovic practices practicing medicine in Podgorica, Montenegro.
Her clinical expertise encompasses Fibrocystic Breast Disease and Fibroadenoma.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Aleksandra Bozaric-Vuksanovic
Is Aleksandra Bozaric-Vuksanovic a top-rated expert for Fibrocystic Breast Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Aleksandra Bozaric-Vuksanovic is classified as an Experienced expert for Fibrocystic Breast Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Aleksandra Bozaric-Vuksanovic participate in research or clinical trials?
Yes. Aleksandra Bozaric-Vuksanovic has published 11 articles and abstracts on conditions like Fibrocystic Breast Disease. You can view a list of Aleksandra Bozaric-Vuksanovic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- FibroadenomaMs. Bozaric-Vuksanovic isExperienced. Learn about Fibroadenoma.
- Fibrocystic Breast DiseaseMs. Bozaric-Vuksanovic isExperienced. Learn about Fibrocystic Breast Disease.